Effect of glutamine analogue-acivicin on tumor induced angiogenesis in Ehrlich ascites carcinoma

Indian Journal of Experimental Biology

Volumn 43, Issue 5, 2005, Pages 407-413

  Roy, Subhadra ^a   Maity, Putul ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Acivicin; Angiogenesis; Ehrlich ascites tumor

Indexed keywords

ACIVICIN; ANGIOGENESIS INHIBITOR; ISOXAZOLE DERIVATIVE;

ANIMAL; ARTICLE; EHRLICH ASCITES TUMOR; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA, EHRLICH TUMOR; ISOXAZOLES; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC;

EID: 18844401058     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Poster D S, Bruno S, Penta J, Neil G I & McGovren J P, Acivicin, an antitumor antibiotic, Can Clin Trials, 4 (1981) 327.
2. Smulski D R, Huang L L, McCluskey M P, Reeve M J, Vollmer A C, Van Dyk T K & LaRossa R A, Combined, Functional Genomic-Biochemical Approach to Intermediary Metabolism: Interaction of Acivicin, a Glutamine amidotransferase Inhibitor, with Escherichia coli K-12, J Bacteriol, 183 (2001) 3353.
3. Hanahan D & Weinberg R A, The hallmarks of cancer, Cell, 100 (2000) 57.
4. Poster D S, Bruno S, Penta J, Neil G L, & McGovren J P, Acivicin: An antitumor antibiotic, Cancer Clin Trials, 4 (1981) 327.
5. Prajda N, Enyme targets of antiglutamine agents in cancer chemotherapy, Adv Enzyme Regul, 24 (1985) 207.
6. Smith T K, Ikeda Y, Fujii J, Taniguchi N & Meister A, Different sites of acivicin binding and inactivation of gamma-glutamyl transpeptidases, Proc Natl Acad Sci USA, 92 (1985) 2360.
7. Weber G, Natsumeda Y, Lui M S, Faderan M A, Liepnieks J J & Elliott W, Control of enzymatic programs and nucleotide pattern in cancer by acivicin and tiaofurin, Adv Enzyme Regul, 22 (1984) 69.
8. Holcenberg J S, Enhanced effect of an L-Glutamine antagonist, L-(αs,5S)-α-Amino-3-chloro-4,5-dihydro-5-isoxaoleacetic acid, by Acinetobacter L-Glutaminase-L-Asparaginase, Cancer Treat Rep, 63 (1979) 1109.
9. Bhattacharya P, Sett S & Maity P, Effect of purified glutaminase from human ascites fluid on experimental tumor bearing mice, J Exp Clin Cancer Research, 20 (2001) 599.
10. Joris I, DeGirolami U, Wortham K & Majno G, Vascular labeling with monastral blue B, Stain Technol, 57 (1982) 77.
11. Tripathi R C & Tripathi B J, A new method for light and electron microscopic localization of fluorescein-labelled dextran in ocular tissue using epoxy-resin embedding, Exp Eye Res, 25 (1977) 259.
12. Nagy J A, Herzberg K T, Masse E M, Zientara G P & Dvorak H F, Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor bearing, normal and serotonin injected mice, Cancer Res, 49 (1989) 5448.
13. Dvorak H F, Nagy J A, Dvorak J T & Dvorak A M, Identification and characterization of blood vessels in solid tumors that are leaky to circulating macromolecules, Am J Pathol, 133 (1988) 95.
14. Jayaram H N, Ardalan B, Deas M & Johnson R K, Mechanism of resistance of a variant of P388 leukemia to L-(alpha S, 5S)-alpha-amino-3-chloro-4, 5-dihydro-5-isoxaoleacetic acid (acivicin), Cancer Res, 45 (1985) 207.
15. Lyons S D, Sant M E & Christopherson R I, Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia, J Biol Chem, 265 (1990) 11377.
16. Hussein A D & Walter R D, Purification and characterization of gamma-glutamyl transpeptidase from Ascaris suum, Mol Biochem Parasitol, 77 (1996) 41.
17. Elloitt W L & Weber G, In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma, Biochem Pharmacol, 34 (1985) 243.
18. Aoki T & Oya H, Inactivation of Crithidia fasciculata carbamoyl phosphate synthase II by the antitumor drug acivicin, Mol Biochem Parasitol, 23 (1987) 173.
19. Senfer D R, Galli S J, Dvorak A M, Perui C A, Harvey V S & Dvorak H F, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid, Science, 219 (1983) 983.
20. Dvorak H F, Nagy J A, Feng D, Brown L F & Dvorak A M, Vascular permeability factor/Vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis, Curr Top Microbial Immunol, 237 (1999) 97.
21. Costantini V & Zacharski L R, The role of fibrin in tumor metastasis, Cancer Metastasis Rev, 11 (1992) 283.
22. Dvorak H F, Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing, N Engl J Med, 315 (1986) 1650.
23. Dvorak H F, Harvey V S, Estrella P, Brown L F, McDonagh J & Dvorak A M, Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing, Lab Invest, 57 (1987) 673.
24. Dvorak H F, Nagy J A, Berse B, Brown L F, Yeo K T, Yeo T K, Dvorak A M, van de Water L, Sioussat T M & Senger D R, Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation, Ann N Y Acad Sci, 667 (1992) 101.
25. Nehls V & Herrmann R, The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration, Microvasc Res, 51 (1996) 347.
26. Collen A, Koolwijk P, Kroon M & van Hinsberg V W, The influence of fibrin structure on the formation and maintenance of capillary-like tubules, Angiogenesis, 2 (1998) 153.